- Home
- PACB vs KMDA Comparison
PACB vs KMDA Comparison
Compare PACB & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACB
- KMDA
- Stock Information
- Founded
- PACB 2000
- KMDA 1990
- Country
- PACB United States
- KMDA Israel
- Employees
- PACB N/A
- KMDA 374
- Industry
- PACB Biotechnology: Laboratory Analytical Instruments
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- PACB Industrials
- KMDA Health Care
- Exchange
- PACB Nasdaq
- KMDA Nasdaq
- Market Cap
- PACB 364.2M
- KMDA 399.7M
- IPO Year
- PACB 2010
- KMDA N/A
- Fundamental
- Price
- PACB $0.99
- KMDA $6.89
- Analyst Decision
- PACB Buy
- KMDA Strong Buy
- Analyst Count
- PACB 9
- KMDA 3
- Target Price
- PACB $2.34
- KMDA $14.67
- AVG Volume (30 Days)
- PACB 9.9M
- KMDA 78.2K
- Earning Date
- PACB 05-08-2025
- KMDA 05-14-2025
- Dividend Yield
- PACB N/A
- KMDA 2.92%
- EPS Growth
- PACB N/A
- KMDA 31.21
- EPS
- PACB N/A
- KMDA 0.28
- Revenue
- PACB $152,357,000.00
- KMDA $167,235,000.00
- Revenue This Year
- PACB $4.67
- KMDA $14.60
- Revenue Next Year
- PACB $19.09
- KMDA $9.23
- P/E Ratio
- PACB N/A
- KMDA $24.49
- Revenue Growth
- PACB N/A
- KMDA 11.83
- 52 Week Low
- PACB $0.85
- KMDA $4.74
- 52 Week High
- PACB $2.72
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- PACB 41.44
- KMDA 48.88
- Support Level
- PACB $0.85
- KMDA $6.56
- Resistance Level
- PACB $1.15
- KMDA $7.06
- Average True Range (ATR)
- PACB 0.08
- KMDA 0.22
- MACD
- PACB 0.00
- KMDA -0.02
- Stochastic Oscillator
- PACB 38.07
- KMDA 17.31
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.